Spiorad Medical is developing a specialized closure device for large French 12F-24F femoral artery access sites, aimed at enhancing procedural efficiency for interventionalists. This technology addresses the challenge of achieving secure closure while optimizing patient recovery outcomes.
Funding
Funding not disclosed
Founders
Product
Problem
Interventionalists face challenges in achieving secure and efficient closure of large French 12F-24F femoral artery access sites after procedures. Current closure methods may not be optimal, potentially leading to complications and prolonged patient recovery times.
Solution
Spiorad Medical is developing a specialized closure device designed to simplify and improve the closure of large French 12F-24F femoral artery access sites. The device aims to provide interventionalists with an easier-to-use solution that promotes better clinical outcomes and faster patient recovery. By focusing on procedural efficiency and secure closure, Spiorad Medical seeks to address the unmet needs in large-bore femoral artery access site management. The technology is being developed with the goal of optimizing both the interventionalist's experience and the patient's post-procedure recovery.
Target Audience
The primary target audience includes interventional cardiologists and vascular surgeons who perform procedures requiring large French femoral artery access.
Features
- Specialized closure device for large French 12F-24F femoral artery access sites
- Designed for ease of use during interventional procedures
- Aims to enhance procedural efficiency for interventionalists
- Focuses on secure closure of the femoral artery
- Seeks to optimize patient recovery outcomes